"The first shot": the context of first injection of illicit drugs, ongoing injecting practices, and hepatitis C infection in Rio de Janeiro, Brazil

The context of first drug injection and its association with ongoing injecting practices and HCV (hepatitis C virus) infection were investigated. Injection drug users (IDUs) (N = 606) were recruited in "drug scenes" (public places, bars) in Rio de Janeiro, Brazil, interviewed, and tested f...

ver descrição completa

Detalhes bibliográficos
Autores: Oliveira, Maria de Lourdes Aguiar, Hacker, Mariana A., Oliveira, Sabrina Alberti Nóbrega de, Telles, Paulo Roberto, Ó, Kycia Maria Rodrigues do, Yoshida, Clara Fumiko Tachibana, Bastos, Francisco I.
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2006
País:Brasil
Recursos:Fundação Oswaldo Cruz (FIOCRUZ)
Repositorio:Cadernos de Saúde Pública
Idioma:inglés
OAI Identifier:oai:ojs.teste-cadernos.ensp.fiocruz.br:article/2745
Acesso em linha:https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2745
Access Level:acceso abierto
Palavra-chave:Intravenous Substance Abuse
Needle Sharing
Hepatitis C Virus
Street Drugs
Descrição
Resumo:The context of first drug injection and its association with ongoing injecting practices and HCV (hepatitis C virus) infection were investigated. Injection drug users (IDUs) (N = 606) were recruited in "drug scenes" (public places, bars) in Rio de Janeiro, Brazil, interviewed, and tested for HCV. Sharing of needles/syringes was more prevalent at the first injection (51.3%) than at the baseline interview (36.8%). Those who shared syringes/needles at first injection were more likely to be currently engaged in direct/indirect sharing practices. Among young injectors (< 30 years), those reporting sharing of needles/ syringes at the first injection were about four times more likely to have been infected by HCV. Hepatitis C virus prevalence among active IDUs (n = 272) was 11%. Prison history and longer duration of drug injection were identified as independent predictors of HCV infection. To effectively curb HCV transmission among IDUs and minimize harms associated with risk behaviors, preventive strategies should target individuals initiating drug injection beginning with their very first injection and discourage the transition from non-injecting use to the self-injection of illicit drugs.